Medical Eligibility as a Predictor of Continued Copper Intrauterine Device (IUD-Cu) Use: A Correlational Analysis

Esa Risi Suazini; Wikky Fawwaz  Al Maki; Widya Hary  Cahyati

doi:10.56303/jhnresearch.v4i2.427

Authors

Esa Risi Suazini Midwifery Diploma 3, STIKes Karsa Husada Garut, Indonesia
Wikky Fawwaz Al Maki Faculty of Informatic, Telkom University, Bandung, Indonesia
Widya Hary Cahyati Faculty of Medicine, Universitas Negeri Semarang, Semarang, Indonesia

Keywords:

Acceptors, Contraceptive Screening, Contraceptive Sustainability, IUD-Cu, Medical Eligibility

Abstract

Approximately 60% of acceptors expressed dissatisfaction with contraceptive counseling services, which has resulted in a 0.7% decrease in modern contraceptive use in the last five years. One important factor in the sustainability of contraceptive use is the suitability of the acceptor's medical condition. This study aimed to determine the relationship between medical appropriateness and plans for continued use of the IUD-Cu. This study used a descriptive correlational design with a cross-sectional approach. Data were collected through structured interviews using a Medical Eligibility Criteria (MEC) application-based questionnaire. This application was created by WHO based on the 5th edition of the 2015 MEC for Contraceptive use guidebook. The sample was purposively selected, and 280 IUD-Cu acceptors were obtained. Univariate analysis was performed with frequency distribution and categorization of medical eligibility, while bivariate analysis used Chi-Square test and Prevalence Ratio (PR) with 95% CI. The results showed that 92.9% of acceptors were medically fit to use IUD-Cu, while 7.1% were not fit. A total of 12.1% of acceptors planned to change contraceptives. There was a significant association between medical eligibility and plans to continue using the IUD-Cu (p = 0.000; PR = 3.077; 95% CI: 1.574-6.015), indicating that medically eligible acceptors had 3.077 times greater potential to continue using the IUD-Cu than those who were not eligible. Therefore, it is recommended to optimize pre-installation screening of IUD-Cu with medical criteria-based tools so that the sustainability of contraceptive use can be maintained and women's reproductive rights are maximally fulfilled.

Downloads

Download data is not yet available.

References

Wijayanti UT. Faktor-Faktor yang Berhubungan dengan Penggunaan Metode Kontrasepsi Tradisional. J Promosi Kesehat Indones. 2021;16(1):14–22.

Nelson HD, Cantor A, Jungbauer RM, Eden KB, Darney B, Ahrens K, et al. Effectiveness and Harms of Contraceptive Counseling and Provision Interventions for Women: A Systematic Review and Meta-analysis. Ann Intern Med. 2022;175(7):980–93.

Christine Dehlendorf, MD M. Contraception: Counseling and selection. In: Eckler CASK, editor. Uptodate. 1st ed. America: UpToDate; 2020. p. 1–46.

Serfaty D. Update on the contraceptive contraindications. J Gynecol Obstet Hum Reprod. 2019;48(5):297–307.

Woodhams EJ, Gilliam M. Contraception. Ann Intern Med. 2019;170(3):ITC17–31.

Carlin CS, Fertig AR, Dowd BE. Affordable care act’s mandate eliminating contraceptive cost sharing influenced choices of women with employer coverage. Health Aff. 2016;35(9):1608–15.

Ermias Y, Averbach SH, Dey AK, Gebrehanna E, Holt K. The association between quality of contraceptive counseling and selection of contraceptive method post-counseling among women in Ethiopia. Contraception. 2023;124:110060.

Yu Y, Zhou Z, Wang L, Liu J. Effect of Mirena Intrauterine Device on Endometrial Thickness, Quality of Life Score, and Curative Effect in Patients with Perimenopausal Abnormal Uterine Bleeding. Comput Math Methods Med. 2022;2022.

Festin MPR. Overview of modern contraception. Best Pract Res Clin Obstet Gynaecol. 2020;66:4–14.

Coulibaly A, Baguiya A, Kpebo D, Zango A, Tougri H, Garanet F, et al. Factors associated with the discontinuation of modern contraceptive methods among lactating women in nine West African high-fertility countries: findings of the most recent demographic and health surveys. Arch Public Heal. 2025;83(1).

Widiantari K, Chania MP. The Role of Field Officers of Family Planning (FOFP) in The Unmet-Need Incidents on The Productive Age Couples. J Kebidanan. 2022;11(2):211.

World Health Organization. Medical eligibility criteria for contraceptive use - Executive summary. In: WHO, editor. Department of Reproductive Health and Research World Health Organization. 5th ed. Geneva, Switzerland: Department of Reproductive Health and Research World Health Organization; 2015. p. 268.

Xue W, Heffernan C. Therapeutic communication within the nurse–patient relationship: A concept analysis. Int J Nurs Pract. 2021;27(6):1–8.

Ewerling F, Victora CG, Raj A, Coll CVN, Hellwig F, Barros AJD. Demand for family planning satisfied with modern methods among sexually active women in low- and middle-income countries: Who is lagging behind? Reprod Health. 2018;15(1):1–10.

Çalikoğlu EO, Yerli EB, Kavuncuoğlu D, Yılmaz S, Koşan Z, Aras A. Use of family planning methods and influencing factors among women in Erzurum. Med Sci Monit. 2018;24:5027–34.

World Health Organization (WHO). World Family Planning. In: United Nations. 1st ed. United Nations; 2022. p. 43.

Nguyen AT, Curtis KM, Tepper NK, Kortsmit K, Brittain AW, Snyder EM, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Jones TF at all, editor. Vol. 73, MMWR Recommendations and Reports. U.S Departement of Health and Human Services: Morbidity and Mortality Weekly Report; 2024. 1–126 p.

Aksari ST. Karakteristik Kelayakan Pemakaian Kontrasepsi Suntik 3 Bulan ( Dmpa ) Di Praktik Mandiri Bidan “ S ” Kesugihan Cilacap. Media Berbagi Keperawatan. 2020;3(1):7–12.

Baker CC, Creinin MD. Long-Acting Reversible Contraception. Obstet Gynecol. 2022;140(5):883–97.

Jaffery SN, Mubarik F, Zubair F, Laique T. Percentage of menorrhagia leading to iron deficiency anemia in non hormonal intrauterine device users. Pakistan J Med Heal Sci. 2021;15(1):204–5.

Harris ML, Feyissa TR, Bowden NA, Gemzell-Danielsson K, Loxton D. Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis. BMC Med. 2022;20(1):1–15.

Curry A, Williams T, Penny ML. Pelvic inflammatory disease: Diagnosis, management, and prevention. Am Fam Physician. 2019;100(6):357–64.

Buitrago Ramírez F, Ciurana Misol R, Fernández Alonso M del C, Tizón JL. Prevention of mental health disorders in primary care: Pregnancy in adolescence. Aten Primaria. 2022;54:102494.

Moreau C, Bohet A, Hassoun D, Teboul M, Bajos N. Trends and determinants of use of long-acting reversible contraception use among young women in France: Results from three national surveys conducted between 2000 and 2010. Fertil Steril. 2013;100(2):451–8.

Redeker NS. Sleep Health in Women of Childbearing Age. J Women’s Heal. 2020;29(3):430–4.

Branger B, Priou E, David P. Copper-containing intrauterine device (cIUD): Comparison of tolerance and efficacy in nulliparous and parous women over 6 months. Gynecol Obstet Fertil Senol. 2021;49(12):897–906.

WHO. Rekomendasi Praktik Terpilih pada Penggunaan Kontrasepsi. Diadaptasi dari buku “Selected Pract Recomm Contracept Use” Third Ed 2016. 2016;1(1):72.

Rohmah HNF. Penyuluhan Pemilihan Alat Kontrasepsi Sesuai Kondisi Kesehatan Akseptor. SELAPARANG J Pengabdi Masy Berkemajuan. 2022;6(3):1375.

Li L, Li J, Li N, Zhang Y, Feng X. Analysis of the reason of abnormal uterine bleeding induced by copper corrosion of IUD Cu. Clin Exp Obstet Gynecol. 2016;43(6):883–6.

Gunardi ER, Putri RA, Pasidri Y. A prospective study of effectivity, expulsion, and acceptability of post-placental iud cu t380a insertion using clamp in a tertiary hospital. J South Asian Fed Obstet Gynaecol. 2021;13(2):92–6.

Kamwesigye A, Amanya D, Epuitai J. Barriers and enablers to utilisation of postpartum long-acting reversible contraception in Eastern Uganda: a qualitative study. Contracept Reprod Med. 2024;5.